Trials / Unknown
UnknownNCT04070690
The Influences of Dialysate Bicarbonate Concentrations on Hemodialysis Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Camillians Saint Mary's Hospital Luodong · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Background: Patients with decreased kidney function are in the positive acid balance due to insufficient renal acid excretion. To correct the varying degrees of metabolic acidosis in these HD patients, a high concentration of HCO3 in the dialysate is routinely used. During every 3-to-4 hours of HD treatment, a massive surge of HCO3 would enter the circulation and typically overcorrects predialysis acidosis to alkalosis and alkalemia. The sharp acid-base shift can cause some adverse consequences. The investigators believe that the rapid correction (or overcorrection) from the pre-dialysis metabolic acidosis to post-dialysis metabolic alkalosis during the 3-to-4 hours HD treatment would relate to adverse effects on HD patients. Thus the investigators conduct this study to prove the hypothesis that "prevention of post-dialysis alkalosis by using lower dialysate HCO3 concentration might cause less adverse outcomes in ESRD patients on HD." Study design: Prospective cross-over case-control study. Study population: A total of 60 patients who receive regular hemodialysis (three times per week) for more than 6 months in the regional teaching hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Concentration of dialysate bicarbonate | Adjust the dialysate bicarbonate concentration |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2020-01-01
- Completion
- 2020-02-01
- First posted
- 2019-08-28
- Last updated
- 2019-08-28
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04070690. Inclusion in this directory is not an endorsement.